|
|
|
Corporate Profile: Rexahn Pharmaceuticals
| Summary: |
Rexahn Pharmaceuticals is focused on development of treatments for cancer and disorders of the central nervous system (CNS).
|
| Address (HQ): |
15245 Shady Grove Road
Suite 455
Rockville, MD 20850 |
| Phone
#'s (HQ): |
| Main |
(240) 268-5300 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
(240) 268-5310 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| RNN |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
